Clinical trials
Observational Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 11 |
| 2022 | 8 |
| 2023 | 12 |
| 2024 | 10 |
| 2025 | 14 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 32 |
| Unknown status | 22 |
| Completed | 19 |
| Not yet recruiting | 12 |
| Active, not recruiting | 10 |
| Terminated | 5 |
| Suspended | 3 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Fudan University | 3 |
| Istituti Clinici Scientifici Maugeri SpA | 3 |
| A2 Biotherapeutics Inc. | 2 |
| Centre Jean Perrin | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Hellenic Cooperative Oncology Group | 2 |
| Indiana University | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 108 |
| Breast Neoplasms | 48 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Carcinoma, Renal Cell | 6 |
| Colorectal Neoplasms | 6 |
| Melanoma | 5 |
| Ovarian Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Small Cell Lung Carcinoma | 4 |
| Head and Neck Neoplasms | 3 |
Trials
Showing 51 to 75 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.